Global Market Study on Intravitreal (IVT) Injectables: Chronic Retinal Conditions to Uplift Sales of Anti-VEGF IVT Injectables
Description
Global Market Study on Intravitreal (IVT) Injectables: Chronic Retinal Conditions to Uplift Sales of Anti-VEGF IVT Injectables
Intravitreal (IVT) Injectable Market Analysis 2022-2028
A recent market study published by Persistence Market Research (PMR) on the Intravitreal (IVT) Injectable Market including global industry analysis for 2013-2021 & opportunity assessment for 2022-2028, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the market, growth prospects are obtained with utmost precision.
Intravitreal (IVT) Injectable Market: Segmentation
The global Intravitreal (IVT) Injectable Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Indication
Macular Degeneration
Diabetic Retinopathy
Retinal Vein Occlusion
Endophthalmitis
Others
Drug Class
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals
Distributional Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail-order Pharmacies
Other
Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)
Report Chapters
Chapter 01 – Executive Summary
The report initiates with the executive summary of the Intravitreal (IVT) Injectable Market, which includes a snapshot of key findings and statistics. It also includes market size and revenue distribution of market segments of the market.
Chapter 02 – Market Overview
Readers can find the detailed segmentation of the Intravitreal (IVT) Injectable Market in this chapter, which will help them understand the basics of the market.
Chapter 03 – Key Market Trends
This chapter highlights the key trends impacting the growth of the Intravitreal (IVT) Injectable Market over the forecast period. It also helps reader to understand both - supply side and demand side trends of the market.
Chapter 04 – Key Success Factors
This chapter explains the key macroeconomic factors that are expected to influence the growth of the market during the forecast period. It also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the market, which include the drivers, restraints, and opportunities.
Chapter 05 – Intravitreal (IVT) Injectable Market Demand (Size in US$ Mn) Analysis 2013-2021 and Forecast, 2022-2028
This section highlights the global market pricing analysis. It helps readers to understand the pricing variation of the market in various geographies.
Chapter 06 – Market Background
This chapter explains the key macroeconomic factors, drivers, restraints, and opportunity analysis along with current COVID-19 impact that are expected to influence growth of the Intravitreal (IVT) Injectable Market over the forecast period. Moreover, in-depth information about the market dynamics and their impact on the market have been provided in the successive section.
Chapter 07 – Global Manual Resuscitator Market Analysis 2013-2021 and Forecast 2022-2028, By Drug Class
This section explains the global market value analysis and forecast for the Intravitreal (IVT) Injectable during the forecast period based on Drug Class. It includes a detailed analysis of the historical Intravitreal (IVT) Injectable Market, along with an opportunity analysis of the future. Based on Drug Class, the Intravitreal (IVT) Injectable market is segmented into Anti-VEGF, Corticosteroids, Antibiotics, Antivirals and Antifungals.
Readers can also find the absolute $ opportunity for the current year (2022), and an incremental $ opportunity for the forecast period (2022-2028).
Chapter 08 – Global Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028, by Indication
Based on Indication, the Intravitreal (IVT) Injectable market is segmented into Diabetic Retinopathy, Macular Degeneration, Endophthalmitis, Retinal Vein Occlusions and Others. In this chapter, readers can find information about the key trends and developments in Intravitreal (IVT) Injectable and market attractiveness analysis based on Indication.
Chapter 09 – Global Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028, by Region
This chapter explains how the market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA).
Chapter 10 – North America Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter includes a detailed analysis of growth of North America’s Intravitreal (IVT) Injectable Market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the application and countries in North America.
Chapter 11 – Latin America Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides the growth scenario of the market in Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
Chapter 12 –Europe Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides the growth scenario of the market in Germany, the U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter.
Chapter 13 – South Asia Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides the growth scenario of the Intravitreal (IVT) Injectable Market in India, Thailand, Indonesia, Malaysia and rest of South Asia.
Chapter 14 – East Asia Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter highlights the growth of the market in East Asia by focusing on China, Japan & South Korea. This section also helps readers understand the key factors that are responsible for the growth of the Intravitreal (IVT) Injectable Market in East Asia.
Chapter 15 – Oceania Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter highlights the growth of the Intravitreal (IVT) Injectable Market in Oceania. It also helps readers understand the key factors that are responsible for the growth of the Intravitreal (IVT) Injectable Market in Australia and New Zealand.
Chapter 16 – MEA Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides information about how the Intravitreal (IVT) Injectable Market will grow in GCC Countries, South Africa, Turkey and the Rest of MEA during the forecast period.
Chapter 17 – Key and Emerging Countries Intravitreal (IVT) Injectable Market Analysis 2013-2021 and Forecast 2022-2028
This section delves deep into Intravitreal (IVT) Injectable Market for key and emerging countries. Readers can understand the market value and volume by product type, modality,and end user for key countries.
Chapter 18 – Market Structure Analysis
This chapter highlights the tier structure analysis, market concentration analysis, and company share analysis along with sales footprint analysis of key players operating in Intravitreal (IVT) Injectable Market.
Chapter 19 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the Intravitreal (IVT) Injectable Market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Novartis AG, Allergan, Alimera Sciences, ThromboGenics, Inc., and Bristol-Myers Squibb Company.
Chapter 20 – Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the Intravitreal (IVT) Injectable report.
Chapter 21 – Research Methodology
This chapter helps readers understand the research component methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the Intravitreal (IVT) Injectable Market.
Intravitreal (IVT) Injectable Market Analysis 2022-2028
A recent market study published by Persistence Market Research (PMR) on the Intravitreal (IVT) Injectable Market including global industry analysis for 2013-2021 & opportunity assessment for 2022-2028, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the market, growth prospects are obtained with utmost precision.
Intravitreal (IVT) Injectable Market: Segmentation
The global Intravitreal (IVT) Injectable Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Indication
Macular Degeneration
Diabetic Retinopathy
Retinal Vein Occlusion
Endophthalmitis
Others
Drug Class
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals
Distributional Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail-order Pharmacies
Other
Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)
Report Chapters
Chapter 01 – Executive Summary
The report initiates with the executive summary of the Intravitreal (IVT) Injectable Market, which includes a snapshot of key findings and statistics. It also includes market size and revenue distribution of market segments of the market.
Chapter 02 – Market Overview
Readers can find the detailed segmentation of the Intravitreal (IVT) Injectable Market in this chapter, which will help them understand the basics of the market.
Chapter 03 – Key Market Trends
This chapter highlights the key trends impacting the growth of the Intravitreal (IVT) Injectable Market over the forecast period. It also helps reader to understand both - supply side and demand side trends of the market.
Chapter 04 – Key Success Factors
This chapter explains the key macroeconomic factors that are expected to influence the growth of the market during the forecast period. It also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the market, which include the drivers, restraints, and opportunities.
Chapter 05 – Intravitreal (IVT) Injectable Market Demand (Size in US$ Mn) Analysis 2013-2021 and Forecast, 2022-2028
This section highlights the global market pricing analysis. It helps readers to understand the pricing variation of the market in various geographies.
Chapter 06 – Market Background
This chapter explains the key macroeconomic factors, drivers, restraints, and opportunity analysis along with current COVID-19 impact that are expected to influence growth of the Intravitreal (IVT) Injectable Market over the forecast period. Moreover, in-depth information about the market dynamics and their impact on the market have been provided in the successive section.
Chapter 07 – Global Manual Resuscitator Market Analysis 2013-2021 and Forecast 2022-2028, By Drug Class
This section explains the global market value analysis and forecast for the Intravitreal (IVT) Injectable during the forecast period based on Drug Class. It includes a detailed analysis of the historical Intravitreal (IVT) Injectable Market, along with an opportunity analysis of the future. Based on Drug Class, the Intravitreal (IVT) Injectable market is segmented into Anti-VEGF, Corticosteroids, Antibiotics, Antivirals and Antifungals.
Readers can also find the absolute $ opportunity for the current year (2022), and an incremental $ opportunity for the forecast period (2022-2028).
Chapter 08 – Global Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028, by Indication
Based on Indication, the Intravitreal (IVT) Injectable market is segmented into Diabetic Retinopathy, Macular Degeneration, Endophthalmitis, Retinal Vein Occlusions and Others. In this chapter, readers can find information about the key trends and developments in Intravitreal (IVT) Injectable and market attractiveness analysis based on Indication.
Chapter 09 – Global Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028, by Region
This chapter explains how the market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA).
Chapter 10 – North America Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter includes a detailed analysis of growth of North America’s Intravitreal (IVT) Injectable Market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the application and countries in North America.
Chapter 11 – Latin America Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides the growth scenario of the market in Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
Chapter 12 –Europe Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides the growth scenario of the market in Germany, the U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter.
Chapter 13 – South Asia Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides the growth scenario of the Intravitreal (IVT) Injectable Market in India, Thailand, Indonesia, Malaysia and rest of South Asia.
Chapter 14 – East Asia Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter highlights the growth of the market in East Asia by focusing on China, Japan & South Korea. This section also helps readers understand the key factors that are responsible for the growth of the Intravitreal (IVT) Injectable Market in East Asia.
Chapter 15 – Oceania Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter highlights the growth of the Intravitreal (IVT) Injectable Market in Oceania. It also helps readers understand the key factors that are responsible for the growth of the Intravitreal (IVT) Injectable Market in Australia and New Zealand.
Chapter 16 – MEA Intravitreal (IVT) Injectable Analysis 2013-2021 and Forecast 2022-2028
This chapter provides information about how the Intravitreal (IVT) Injectable Market will grow in GCC Countries, South Africa, Turkey and the Rest of MEA during the forecast period.
Chapter 17 – Key and Emerging Countries Intravitreal (IVT) Injectable Market Analysis 2013-2021 and Forecast 2022-2028
This section delves deep into Intravitreal (IVT) Injectable Market for key and emerging countries. Readers can understand the market value and volume by product type, modality,and end user for key countries.
Chapter 18 – Market Structure Analysis
This chapter highlights the tier structure analysis, market concentration analysis, and company share analysis along with sales footprint analysis of key players operating in Intravitreal (IVT) Injectable Market.
Chapter 19 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the Intravitreal (IVT) Injectable Market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Novartis AG, Allergan, Alimera Sciences, ThromboGenics, Inc., and Bristol-Myers Squibb Company.
Chapter 20 – Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the Intravitreal (IVT) Injectable report.
Chapter 21 – Research Methodology
This chapter helps readers understand the research component methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the Intravitreal (IVT) Injectable Market.
Table of Contents
276 Pages
- 1. Executive Summary
- 1.1. Market Overview
- 1.2. Market Analysis
- 1.3. FMI Analysis and Recommendations
- 2. Market Introduction
- 2.1. Market Taxonomy
- 2.2. Market Definition
- 3. Key Inclusions and Exclusions
- 4. Market Opportunity Analysis
- 4.1. Macro-Economic Factors
- 4.2. Opportunity Analysis
- 5. Market Dynamics
- 5.1. Drivers
- 5.1.1. Supply Side Drivers
- 5.1.2. Demand Side Drivers
- 5.2. Restraints
- 5.3. Trends
- 6. Epidemiology Analysis
- 7. Reimbursement Guidelines
- 8. Pipeline Analysis
- 9. Global Economic Outlook
- 9.1. Gross Domestic Indication Type by Region & Country, 2006 – 2021
- 9.2. Global Healthcare Market Indicators
- 10. Global Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028, by Drug Class
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Mn) By Drug Class, 2013–2021
- 10.2.1. Anti-VEGF
- 10.2.2. Corticosteroids
- 10.2.3. Antibiotics
- 10.2.4. Antivirals
- 10.2.5. Antifungals
- 10.3. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
- 10.4. Market Attractiveness Analysis By Drug Class
- 11. Global Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028, by Indication
- 11.1. Introduction / Key Findings
- 11.2. Historical Market Size (US$ Mn) By Indication, 2013–2021
- 11.2.1. Diabetic Retinopathy
- 11.2.2. Macular Degeneration
- 11.2.3. Endophthalmitis
- 11.2.4. Retinal Vein Occlusions
- 11.2.5. Others
- 11.3. Market Size (US$ Mn) Forecast By Indication, 2022–2028
- 11.4. Market Attractiveness Analysis By Indication
- 12. Global Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028, by Distributional Channel
- 12.1. Introduction / Key Findings
- 12.2. Historical Market Size (US$ Mn) By Distributional Channel, 2013–2021
- 12.2.1. Hospital Pharmacies
- 12.2.2. Retail Pharmacies
- 12.2.3. Drug Stores
- 12.2.4. Mail Order Pharmacies
- 12.2.5. Others
- 12.3. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
- 12.4. Market Attractiveness Analysis By Distributional Channel
- 13. Global Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028, by Region
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Mn) By Region, 2013–2021
- 13.2.1. North America
- 13.2.2. Latin America
- 13.2.3. Europe
- 13.2.4. South Asia
- 13.2.5. East Asia
- 13.2.6. Oceania
- 13.2.7. Middle East and Africa
- 13.2.8. Emerging Countries
- 13.3. Market Size (US$ Mn) Forecast By Region, 2022–2028
- 13.4. Market Attractiveness Analysis By Region
- 14. North America Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Mn) and By Country, 2013 – 2017
- 14.2.1. U.S.
- 14.2.2. Canada
- 14.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
- 14.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
- 14.4.1. Anti-VEGF
- 14.4.2. Corticosteriods
- 14.4.3. Antibiotics
- 14.4.4. Antivirals
- 14.4.5. Antifungals
- 14.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
- 14.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
- 14.6.1. Diabetic Retinopathy
- 14.6.2. Macular Degeneration
- 14.6.3. Endophthalmitis
- 14.6.4. Retinal Vein Occlusion
- 14.6.5. Others
- 14.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
- 14.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
- 14.8.1. Hospital Pharmacies
- 14.8.2. Retail Pharmacies
- 14.8.3. Drug Stores
- 14.8.4. Mail Order Pharmacies
- 14.8.5. Others
- 14.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
- 14.10. Market Attractiveness Analysis
- 14.10.1. By Country
- 14.10.2. By Drug Class
- 14.10.3. By Indication
- 14.10.4. By Distributional Channel
- 14.11. Drivers and Restraints: Impact Analysis
- 15. Latin America Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
- 15.2.1. Brazil
- 15.2.2. Mexico
- 15.2.3. Rest of Latin America
- 15.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
- 15.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
- 15.4.1. Anti-VEGF
- 15.4.2. Corticosteriods
- 15.4.3. Antibiotics
- 15.4.4. Antivirals
- 15.4.5. Antifungals
- 15.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
- 15.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
- 15.6.1. Diabetic Retinopathy
- 15.6.2. Macular Degeneration
- 15.6.3. Endophthalmitis
- 15.6.4. Retinal Vein Occlusion
- 15.6.5. Others
- 15.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
- 15.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
- 15.8.1. Hospital Pharmacies
- 15.8.2. Retail Pharmacies
- 15.8.3. Drug Stores
- 15.8.4. Mail Order Pharmacies
- 15.8.5. Others
- 15.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
- 15.10. Market Attractiveness Analysis
- 15.10.1. By Country
- 15.10.2. By Drug Class
- 15.10.3. By Indication
- 15.10.4. By Distributional Channel
- 15.11. Drivers and Restraints: Impact Analysis
- 16. Europe Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
- 16.2.1. Germany
- 16.2.2. Italy
- 16.2.3. France
- 16.2.4. U.K.
- 16.2.5. Spain
- 16.2.6. BENELUX
- 16.2.7. Russia
- 16.2.8. Rest of Europe
- 16.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
- 16.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
- 16.4.1. Anti-VEGF
- 16.4.2. Corticosteriods
- 16.4.3. Antibiotics
- 16.4.4. Antivirals
- 16.4.5. Antifungals
- 16.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
- 16.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
- 16.6.1. Diabetic Retinopathy
- 16.6.2. Macular Degeneration
- 16.6.3. Endophthalmitis
- 16.6.4. Retinal Vein Occlusion
- 16.6.5. Others
- 16.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
- 16.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
- 16.8.1. Hospital Pharmacies
- 16.8.2. Retail Pharmacies
- 16.8.3. Drug Stores
- 16.8.4. Mail Order Pharmacies
- 16.8.5. Others
- 16.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
- 16.10. Market Attractiveness Analysis
- 16.10.1. By Country
- 16.10.2. By Drug Class
- 16.10.3. By Indication
- 16.10.4. By Distributional Channel
- 16.11. Drivers and Restraints: Impact Analysis
- 17. South Asia Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
- 17.1. Introduction
- 17.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
- 17.2.1. India
- 17.2.2. Thailand
- 17.2.3. Indonesia
- 17.2.4. Malaysia
- 17.2.5. Rest of South Asia
- 17.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
- 17.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
- 17.4.1. Anti-VEGF
- 17.4.2. Corticosteriods
- 17.4.3. Antibiotics
- 17.4.4. Antivirals
- 17.4.5. Antifungals
- 17.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
- 17.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
- 17.6.1. Diabetic Retinopathy
- 17.6.2. Macular Degeneration
- 17.6.3. Endophthalmitis
- 17.6.4. Retinal Vein Occlusion
- 17.6.5. Others
- 17.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
- 17.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
- 17.8.1. Hospital Pharmacies
- 17.8.2. Retail Pharmacies
- 17.8.3. Drug Stores
- 17.8.4. Mail Order Pharmacies
- 17.8.5. Others
- 17.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
- 17.10. Market Attractiveness Analysis
- 17.10.1. By Country
- 17.10.2. By Drug Class
- 17.10.3. By Indication
- 17.10.4. By Distributional Channel
- 17.11. Drivers and Restraints: Impact Analysis
- 18. East Asia Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
- 18.1. Introduction
- 18.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
- 18.2.1. China
- 18.2.2. Japan
- 18.2.3. South Korea
- 18.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
- 18.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
- 18.4.1. Anti-VEGF
- 18.4.2. Corticosteriods
- 18.4.3. Antibiotics
- 18.4.4. Antivirals
- 18.4.5. Antifungals
- 18.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
- 18.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
- 18.6.1. Diabetic Retinopathy
- 18.6.2. Macular Degeneration
- 18.6.3. Endophthalmitis
- 18.6.4. Retinal Vein Occlusion
- 18.6.5. Others
- 18.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
- 18.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
- 18.8.1. Hospital Pharmacies
- 18.8.2. Retail Pharmacies
- 18.8.3. Drug Stores
- 18.8.4. Mail Order Pharmacies
- 18.8.5. Others
- 18.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
- 18.10. Market Attractiveness Analysis
- 18.10.1. By Country
- 18.10.2. By Drug Class
- 18.10.3. By Indication
- 18.10.4. By Distributional Channel
- 18.11. Drivers and Restraints: Impact Analysis
- 19. Oceania Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
- 19.1. Introduction
- 19.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
- 19.2.1. Australia
- 19.2.2. New Zealand
- 19.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
- 19.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
- 19.4.1. Anti-VEGF
- 19.4.2. Corticosteriods
- 19.4.3. Antibiotics
- 19.4.4. Antivirals
- 19.4.5. Antifungals
- 19.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
- 19.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
- 19.6.1. Diabetic Retinopathy
- 19.6.2. Macular Degeneration
- 19.6.3. Endophthalmitis
- 19.6.4. Retinal Vein Occlusion
- 19.6.5. Others
- 19.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
- 19.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
- 19.8.1. Hospital Pharmacies
- 19.8.2. Retail Pharmacies
- 19.8.3. Drug Stores
- 19.8.4. Mail Order Pharmacies
- 19.8.5. Others
- 19.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
- 19.10. Market Attractiveness Analysis
- 19.10.1. By Country
- 19.10.2. By Drug Class
- 19.10.3. By Indication
- 19.10.4. By Distributional Channel
- 19.11. Drivers and Restraints: Impact Analysis
- 20. Middle East and Africa Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
- 20.1. Introduction
- 20.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013–2021
- 20.2.1. GCC Countries
- 20.2.2. Turkey
- 20.2.3. Northern Africa
- 20.2.4. South Africa
- 20.2.5. Rest of Middle East and Africa
- 20.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
- 20.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
- 20.4.1. Anti-VEGF
- 20.4.2. Corticosteriods
- 20.4.3. Antibiotics
- 20.4.4. Antivirals
- 20.4.5. Antifungals
- 20.5. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
- 20.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
- 20.6.1. Diabetic Retinopathy
- 20.6.2. Macular Degeneration
- 20.6.3. Endophthalmitis
- 20.6.4. Retinal Vein Occlusion
- 20.6.5. Others
- 20.7. Market Size (US$ Mn) Forecast By Indication, 2022–2028
- 20.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
- 20.8.1. Hospital Pharmacies
- 20.8.2. Retail Pharmacies
- 20.8.3. Drug Stores
- 20.8.4. Mail Order Pharmacies
- 20.8.5. Others
- 20.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
- 20.10. Market Attractiveness Analysis
- 20.10.1. By Country
- 20.10.2. By Drug Class
- 20.10.3. By Indication
- 20.10.4. By Distributional Channel
- 20.11. Drivers and Restraints: Impact Analysis
- 21. Emerging Countries Intravitreal (IVT) Injectables Market Analysis 2013-2021 and Forecast 2022–2028
- 21.1. Introduction
- 21.2. Global Vs. Country Growth Comparison
- 22. China Intravitreal Injectables (IVT) Market Analysis 2013–2021 and Forecast 2022–2028
- 22.1. Introduction
- 22.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
- 22.2.1. Anti-VEGF
- 22.2.2. Corticosteriods
- 22.2.3. Antibiotics
- 22.2.4. Antivirals
- 22.2.5. Antifungals
- 22.2.6. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
- 22.3. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
- 22.3.1. Diabetic Retinopathy
- 22.3.2. Macular Degeneration
- 22.3.3. Endophthalmitis
- 22.3.4. Retinal Vein Occlusion
- 22.3.5. Others
- 22.4. Market Size (US$ Mn) Forecast By Indication, 2022–2028
- 22.5. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
- 22.5.1. Hospital Pharmacies
- 22.5.2. Retail Pharmacies
- 22.5.3. Drug Stores
- 22.5.4. Mail Order Pharmacies
- 22.5.5. Others
- 22.6. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
- 22.7. Market Attractiveness Analysis
- 22.7.1. By Country
- 22.7.2. By Drug Class
- 22.7.3. By Indication
- 22.7.4. By Distributional Channel
- 22.8. PESTLE Analysis
- 22.9. Drivers and Restraints: Impact Analysis
- 23. India Intravitreal Injectables (IVT) Market Analysis 2013–2021 and Forecast 2022–2028
- 23.1. Introduction
- 23.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
- 23.2.1. Anti-VEGF
- 23.2.2. Corticosteriods
- 23.2.3. Antibiotics
- 23.2.4. Antivirals
- 23.2.5. Antifungals
- 23.3. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
- 23.4. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
- 23.4.1. Diabetic Retinopathy
- 23.4.2. Macular Degeneration
- 23.4.3. Endophthalmitis
- 23.4.4. Retinal Vein Occlusion
- 23.4.5. 23.3.5. Others
- 23.5. Market Size (US$ Mn) Forecast By Indication, 2022–2028
- 23.6. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
- 23.6.1. 23.5.1. Hospital Pharmacies
- 23.6.2. 23.5.2. Retail Pharmacies
- 23.6.3. 23.5.3. Drug Stores
- 23.6.4. 23.5.4. Mail Order Pharmacies
- 23.6.5. 23.5.5. Others
- 23.7. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
- 23.8. Market Attractiveness Analysis
- 23.8.1. 23.7.1. By Country
- 23.8.2. 23.7.2. By Drug Class
- 23.8.3. 23.7.3. By Indication
- 23.8.4. 23.7.4. By Distributional Channel
- 23.9. PESTLE Analysis
- 23.10. Drivers and Restraints: Impact Analysis
- 24. Mexico Intravitreal Injectables (IVT) Market Analysis 2013–2021 and Forecast 2022–2028
- 24.1. Introduction
- 24.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2021
- 24.2.1. Anti-VEGF
- 24.2.2. Corticosteriods
- 24.2.3. Antibiotics
- 24.2.4. Antivirals
- 24.2.5. Antifungals
- 24.3. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028
- 24.4. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2021
- 24.4.1. 24.3.1. Diabetic Retinopathy
- 24.4.2. 24.3.2. Macular Degeneration
- 24.4.3. 24.3.3. Endophthalmitis
- 24.4.4. 24.3.4. Retinal Vein Occlusion
- 24.4.5. 24.3.5. Others
- 24.5. Market Size (US$ Mn) Forecast By Indication, 2022–2028
- 24.6. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013–2021
- 24.6.1. 24.5.1. Hospital Pharmacies
- 24.6.2. 24.5.2. Retail Pharmacies
- 24.6.3. 24.5.3. Drug Stores
- 24.6.4. 24.5.4. Mail Order Pharmacies
- 24.6.5. 24.5.5. Others
- 24.7. Market Size (US$ Mn) Forecast By Distributional Channel, 2022–2028
- 24.8. Market Attractiveness Analysis
- 24.8.1. 24.7.1. By Country
- 24.8.2. 24.7.2. By Drug Class
- 24.8.3. 24.7.3. By Indication
- 24.8.4. 24.7.4. By Distributional Channel
- 24.9. PESTLE Analysis
- 24.10. Drivers and Restraints: Impact Analysis
- 25. Forecast Factors: Relevance and Impact
- 26. Forecast Assumptions
- 27. Competition Analysis
- 27.1. Competition Dashboard
- 27.2. Competition Deep Dive
- 27.2.1. F. Hoffmann-La Roche Ltd
- 27.2.1.1. Overview
- 27.2.1.2. Key Financials
- 27.2.1.3. SWOT Analysis
- 27.2.1.4. Key Developments
- 27.2.1.5. Key Strategy
- 27.2.2. Regeneron Pharmaceuticals, Inc.
- 27.2.2.1. Overview
- 27.2.2.2. Key Financials
- 27.2.2.3. SWOT Analysis
- 27.2.2.4. Key Developments
- 27.2.2.5. Key Strategy
- 27.2.3. Bausch & Lomb
- 27.2.3.1. Overview
- 27.2.3.2. Key Financials
- 27.2.3.3. SWOT Analysis
- 27.2.3.4. Key Developments
- 27.2.3.5. Key Strategy
- 27.2.4. Novartis AG
- 27.2.4.1. Overview
- 27.2.4.2. Key Financials
- 27.2.4.3. SWOT Analysis
- 27.2.4.4. Key Developments
- 27.2.4.5. Key Strategy
- 27.2.5. Allergan
- 27.2.5.1. Overview
- 27.2.5.2. Key Financials
- 27.2.5.3. SWOT Analysis
- 27.2.5.4. Key Developments
- 27.2.5.5. Key Strategy
- 27.2.6. Alimera Sciences
- 27.2.6.1. Overview
- 27.2.6.2. Key Financials
- 27.2.6.3. SWOT Analysis
- 27.2.6.4. Key Developments
- 27.2.6.5. Key Strategy
- 27.2.7. ThromboGenics, Inc.
- 27.2.7.1. Overview
- 27.2.7.2. Key Financials
- 27.2.7.3. SWOT Analysis
- 27.2.7.4. Key Developments
- 27.2.7.5. Key Strategy
- 27.2.8. Bristol-Myers Squibb Company
- 27.2.8.1. Overview
- 27.2.8.2. Key Financials
- 27.2.8.3. SWOT Analysis
- 27.2.8.4. Key Developments
- 27.2.8.5. Key Strategy
- 28. Assumptions and Acronyms Used
- 29. Research Methodology
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
